Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20,000
NCT07019870
Screening for Early Diagnosis of Nose Cancer
Phase: N/A
Role: Collaborator
Start: Nov 8, 2022
Completion: Nov 30, 2027